Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis

Lee A. McDermott, Brian Higgins, Mary Simcox, Kin Chun Luk, Tom Nevins, Kenneth Kolinsky, Melissa Smith, Hong Yang, Jia K. Li, Yingsi Chen, June Ke, Navita Mallalieu, Tom Egan, Stan Kolis, Aruna Railkar, Louise Gerber, Jin Jun Liu, Fred Konzelmann, Zhuming Zhang, Tom FlynnOmar Morales, Yi Chen

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

RO4396686 is a small molecule KDR, FGFR, and PDGFR inhibitor with good pharmacokinetic properties in rodents. In a mouse corneal neovascularization assay, this compound inhibited VEGF-induced angiogenesis. Tested in a H460a xenograft tumor model this agent effected significant tumor growth inhibition at doses as low as 50 mg/kg.

Original languageEnglish
Pages (from-to)1950-1953
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume16
Issue number7
DOIs
StatePublished - 1 Apr 2006
Externally publishedYes

Keywords

  • Biological results
  • FGFR
  • Inhibitor
  • KDR
  • PDGFR
  • Pyrimidopyrimidone

Fingerprint

Dive into the research topics of 'Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis'. Together they form a unique fingerprint.

Cite this